Search Results 321-330 of 16378 for anti-TNF drugs

  1. Targeting VEGF-Independent Proangiogenic Pathways in Anti-VEGF Refractory Renal Cell Cancer - Tumor Angiogenesis and Vascular Biology Laboratory - Mayo Clinic Research

    Mukhopadhyay's lab is developing novel treatment strategies to target these pathways for refractory and highly aggressive tumor types and for sarcomatoid renal ...

  2. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

    A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies. Print details.

  3. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

    Giving duvelisib in combination with nivolumab may work better than giving each of these drugs ... methotrexate, azathioprine, anti-tumor necrosis factor (TNF) ...

  4. KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome - Mayo Clinic

    KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome.

  5. High-dose vitamin C: Can it kill cancer cells? - Mayo Clinic

    High-dose vitamin C has been touted by some as an effective alternative cancer treatment.

  6. Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death

    Also, antifungal medications are expensive and can interact with other medications. Therefore, the health care team must monitor anti-fungal medications closely ...

  7. Oncology (Medical) - Clinical trials

    A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

  8. 'Virtual clinical trials' may predict success of heart failure drugs

    Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most ...

  9. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... Use of TNF antagonists;; Use of antagonists of ... Use of anti-adhesion molecules (e.g., anti-MAdCAM-1).

  10. Antidepressants: Get tips to cope with side effects - Mayo Clinic

    If insomnia is an ongoing problem, ask your doctor about taking a sedating medication at bedtime or ask whether taking a low dose of a sedating antidepressant ...